{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T02:43:52Z","timestamp":1768877032463,"version":"3.49.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2011,5,15]],"date-time":"2011-05-15T00:00:00Z","timestamp":1305417600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00417-011-1709-6","type":"journal-article","created":{"date-parts":[[2011,5,14]],"date-time":"2011-05-14T18:14:05Z","timestamp":1305396845000},"page":"1493-1501","source":"Crossref","is-referenced-by-count":18,"title":["Combination of vascular endothelial growth factor receptor\/platelet-derived growth factor receptor inhibition markedly improves the antiangiogenic efficacy for advanced stage mouse corneal neovascularization"],"prefix":"10.1007","volume":"249","author":[{"given":"Zhang","family":"Chaoran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Zhirong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Gezhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,5,15]]},"reference":[{"issue":"4","key":"1709_CR1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00003226-198706040-00004","volume":"6","author":"RJ Epstein","year":"1987","unstructured":"Epstein RJ, Stulting RD, Hendricks RL, Harris DM (1987) Corneal neovascularization. Pathogenesis and inhibition. Cornea 6(4):250\u2013257","journal-title":"Cornea"},{"issue":"3","key":"1709_CR2","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0039-6257(98)00035-6","volume":"43","author":"P Lee","year":"1998","unstructured":"Lee P, Wang CC, Adamis AP (1998) Ocular neovascularization: an epidemiologic review. Surv Ophthalmol 43(3):245\u2013269","journal-title":"Surv Ophthalmol"},{"key":"1709_CR3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/386671a0","volume":"386","author":"W Risau","year":"1997","unstructured":"Risau W (1997) Mechanisms of angiogenesis. Nature 386:671\u2013674","journal-title":"Nature"},{"key":"1709_CR4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF00645048","volume":"270","author":"V Nehls","year":"1992","unstructured":"Nehls V, Denzer K, Drenckhahn D (1992) Pericyte involvement in capillary sprouting during angiogenesis in situ. Cell Tissue Res 270:469\u2013474","journal-title":"Cell Tissue Res"},{"issue":"1","key":"1709_CR5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11864-007-0022-4","volume":"8","author":"E Cabebe","year":"2007","unstructured":"Cabebe E, Wakelee H (2007) Role of anti-angiogenesis agents in treating NSCLC: focus on bevacizumab and VEGFR tyrosine kinase inhibitors. Curr Treat Options Oncol 8(1):15\u201327","journal-title":"Curr Treat Options Oncol"},{"key":"1709_CR6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/archopht.1996.01100130062010","volume":"114","author":"AP Adamis","year":"1996","unstructured":"Adamis AP, Shima DT, Tolentino MJ, Gragoudas ES, Ferrara N, Folkman J, D\u2019Amore PA, Miller JW (1996) Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol 114:66\u201371","journal-title":"Arch Ophthalmol"},{"key":"1709_CR7","first-page":"18","volume":"39","author":"S Amano","year":"1998","unstructured":"Amano S, Rohan R, Kuroki M, Tolentino M, Adamis AP (1998) Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci 39:18\u201322","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1709_CR8","doi-asserted-by":"crossref","first-page":"4851","DOI":"10.1073\/pnas.93.10.4851","volume":"93","author":"GS Robinson","year":"1996","unstructured":"Robinson GS, Pierce EA, Rook SL, Foley E, Webb R, Smith LE (1996) Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. Proc Natl Acad Sci USA 93:4851\u20134856","journal-title":"Proc Natl Acad Sci USA"},{"key":"1709_CR9","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archopht.120.3.338","volume":"120","author":"MG Krzystolik","year":"2002","unstructured":"Krzystolik MG, Afshari MA, Adamis AP, Gaudreault J, Gragoudas ES, Michaud NA, Li W, Connolly E, O\u2019Neill CA, Miller JW (2002) Prevention of experimental choroidal neovascularization with intravitreal anti-vascular endothelial growth factor antibody fragment. Arch Ophthalmol 120:338\u2013346","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"1709_CR10","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/ICO.0b013e31812f6c95","volume":"26","author":"N Singh","year":"2007","unstructured":"Singh N, Higgins E, Amin S, Jani P, Richter E, Patel A, Kaur R, Wang J, Ambati J, Dong Z, Ambati BK (2007) Unique homologous siRNA blocks hypoxia-induced VEGF upregulation in human corneal cells and inhibits and regresses murine corneal neovascularization. Cornea 26(1):65\u201372","journal-title":"Cornea"},{"issue":"5","key":"1709_CR11","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1167\/iovs.04-1172","volume":"46","author":"N Singh","year":"2005","unstructured":"Singh N, Higgins E, Amin S, Jani P, Richter E, Patel A, Kaur R, Wang J, Ambati J, Dong Z, Ambati BK (2005) Flt-1 intraceptors inhibit hypoxia-induced VEGF expression in vitro and corneal neovascularization in vivo. Invest Ophthalmol Vis Sci 46(5):1647\u20131652","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1709_CR12","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1242\/dev.125.9.1591","volume":"125","author":"LE Benjamin","year":"1998","unstructured":"Benjamin LE, Hemo I, Keshet E (1998) A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125:1591\u20131598","journal-title":"Development"},{"key":"1709_CR13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1172\/JCI5028","volume":"103","author":"LE Benjamin","year":"1999","unstructured":"Benjamin LE, Golijanin D, Itin A, Pode D, Keshet E (1999) Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J Clin Invest 103:159\u2013165","journal-title":"J Clin Invest"},{"key":"1709_CR14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1167\/iovs.01-1277","volume":"44","author":"AM Joussen","year":"2003","unstructured":"Joussen AM, Poulaki V, Mitsiades N, Stechschulte SU, Kirchhof B, Dartt DA, Fong GH, Rudge J, Wiegand SJ, Yancopoulos GD, Adamis AP (2003) VEGF-dependent conjunctivalization of the corneal surface. Invest Ophthalmol Vis Sci 44:117\u2013123","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1709_CR15","first-page":"473","volume":"58","author":"AD Proia","year":"1988","unstructured":"Proia AD, Chandler DB, Haynes WL, Smith CF, Suvarnamani C, Erkel FH, Klintworth GK (1988) Quantitation of corneal neovascularization using computerized image analysis. Lab Invest 58:473\u2013479","journal-title":"Lab Invest"},{"issue":"1","key":"1709_CR16","doi-asserted-by":"crossref","first-page":"496","DOI":"10.2353\/ajpath.2010.080642","volume":"176","author":"Q Ebrahem","year":"2010","unstructured":"Ebrahem Q, Chaurasia SS, Vasanji A, Qi JH, Klenotic PA, Cutler A, Asosingh K, Erzurum S, Anand-Apte B (2010) Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo. Am J Pathol 176(1):496\u2013503","journal-title":"Am J Pathol"},{"issue":"10","key":"1709_CR17","first-page":"1963","volume":"38","author":"MS Conners","year":"1997","unstructured":"Conners MS, Urbano F, Vafeas C, Stoltz RA, Dunn MW, Schwartzman ML (1997) Alkali burn-induced synthesis of inflammatory eicosanoids in rabbit corneal epithelium. Invest Ophthalmol Vis Sci 38(10):1963\u20131971","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"1709_CR18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000319749","volume":"45","author":"E Campos-Mollo","year":"2011","unstructured":"Campos-Mollo E, P\u00e9rez-Santonja JJ, Lled\u00f3-Riquelme M, Ortega Pastor E, Ali\u00f3 JL (2011) New corneal neovascularization model in rabbits for angiogenesis research. Ophthalmic Res 45(3):135\u2013141","journal-title":"Ophthalmic Res"},{"issue":"6","key":"1709_CR19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.preteyeres.2006.09.001","volume":"25","author":"DH Ma","year":"2006","unstructured":"Ma DH, Chen JK, Zhang F, Lin KY, Yao JY, Yu JS (2006) Regulation of corneal angiogenesis in limbal stem cell deficiency. Prog Retin Eye Res 25(6):563\u2013590","journal-title":"Prog Retin Eye Res"},{"key":"1709_CR20","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/nm1095-1024","volume":"1","author":"T Alon","year":"1995","unstructured":"Alon T, Hemo I, Itin A, Pe\u2019er J, Stone J, Keshet E (1995) Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1:1024\u20131028","journal-title":"Nat Med"},{"key":"1709_CR21","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1073\/pnas.92.3.905","volume":"92","author":"EA Pierce","year":"1995","unstructured":"Pierce EA, Avery RL, Foley ED, Aiello LP, Smith LE (1995) VEGF expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 92:905\u2013909","journal-title":"Proc Natl Acad Sci USA"},{"key":"1709_CR22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.yexcr.2005.11.012","volume":"312","author":"M Shibuya","year":"2006","unstructured":"Shibuya M, Claesson-Welsh L (2006) Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 312:549\u2013560","journal-title":"Exp Cell Res"},{"key":"1709_CR23","first-page":"1883","volume":"162","author":"MS Gee","year":"2003","unstructured":"Gee MS, Procopio WN, Makonnen S, Feldman MD, Yeilding NM, Lee WM (2003) Tumor vessel development and maturation impose limits on the effectiveness of anti-vascular therapy. Am J Pathol 162:1883\u2013193","journal-title":"Am J Pathol"},{"issue":"3","key":"1709_CR24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1084\/jem.20091846","volume":"207","author":"I Helfrich","year":"2010","unstructured":"Helfrich I, Scheffrahn I, Bartling S, Weis J, von Felbert V, Middleton M, Kato M, Erg\u00fcn S, Schadendorf D (2010) Resistance to antiangiogenic therapy is directed by vascular phenotype, vessel stabilization, and maturation in malignant melanoma. J Exp Med 207(3):491\u2013503","journal-title":"J Exp Med"},{"issue":"1","key":"1709_CR25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/bjo.87.1.101","volume":"87","author":"C Cursiefen","year":"2003","unstructured":"Cursiefen C, Hofmann-Rummelt C, K\u00fcchle M, Schl\u00f6tzer-Schrehardt U (2003) Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation. Br J Ophthalmol 87(1):101\u2013106","journal-title":"Br J Ophthalmol"},{"key":"1709_CR26","first-page":"637","volume":"34","author":"VPT Hoppenreijs","year":"1993","unstructured":"Hoppenreijs VPT, Pels E, Vrensen GF, Felten PC, Treffers WF (1993) Platelet-derived growth factor: receptor expression in corneas and effects on corneal cells. Invest Ophthalmol Vis Sci 34:637\u2013649","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"1709_CR27","first-page":"1364","volume":"40","author":"WJ Kim","year":"1999","unstructured":"Kim WJ, Mohan RR, Mohan RR, Wilson SE (1999) Effect of PDGF, IL-1alpha, and BMP2\/4 on corneal fibroblast chemotaxis: expression of the platelet-derived growth factor system in the cornea. Invest Ophthalmol Vis Sci 40(7):1364\u20131372","journal-title":"Invest Ophthalmol Vis Sci."},{"issue":"8","key":"1709_CR28","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1172\/JCI200318549","volume":"112","author":"A Abramsson","year":"2003","unstructured":"Abramsson A, Lindblom P, Betsholtz C (2003) Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest 112(8):1142\u20131151","journal-title":"J Clin Invest"},{"issue":"15","key":"1709_CR29","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1101\/gad.266803","volume":"17","author":"P Lindblom","year":"2003","unstructured":"Lindblom P, Gerhardt H, Liebner S, Abramsson A, Enge M, Hellstrom M, Backstrom G, Fredriksson S, Landegren U, Nystrom HC, Bergstrom G, Dejana E, Ostman A, Lindahl P, Betsholtz C (2003) Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes Dev 17(15):1835\u20131840","journal-title":"Genes Dev"},{"issue":"8","key":"1709_CR30","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1172\/JCI200320087","volume":"112","author":"RK Jain","year":"2003","unstructured":"Jain RK, Booth MF (2003) What brings pericytes to tumor vessels? J Clin Invest 112(8):1134\u20131136","journal-title":"J Clin Invest"},{"issue":"7","key":"1709_CR31","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1096\/fj.00-0693fje","volume":"15","author":"N Reinmuth","year":"2001","unstructured":"Reinmuth N, Liu W, Jung YD, Ahmad SA, Shaheen RM, Fan F, Bucana CD, McMahon G, Gallick GE, Ellis LM (2001) Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J 15(7):1239\u20131241","journal-title":"FASEB J"},{"issue":"4","key":"1709_CR32","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1215\/S1152851705000232","volume":"7","author":"G Bergers","year":"2005","unstructured":"Bergers G, Song S (2005) The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 7(4):452\u2013464","journal-title":"Neuro Oncol"},{"issue":"12","key":"1709_CR33","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1002\/ijc.22999","volume":"121","author":"Y Hasumi","year":"2007","unstructured":"Hasumi Y, K\u0142osowska-Wardega A, Furuhashi M, Ostman A, Heldin CH, Hellberg C (2007) Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling. Int J Cancer 121(12):2606\u20132614","journal-title":"Int J Cancer"},{"issue":"2","key":"1709_CR34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1096\/fj.03-0271fje","volume":"18","author":"R Erber","year":"2004","unstructured":"Erber R, Thurnher A, Katsen AD, Groth G, Kerger H, Hammes HP, Menger MD, Ullrich A, Vajkoczy P (2004) Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. FASEB J 18(2):338\u2013340","journal-title":"FASEB J"},{"issue":"9","key":"1709_CR35","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1172\/JCI200317929","volume":"111","author":"G Bergers","year":"2003","unstructured":"Bergers G, Song S, Meyer-Morse N, Bergsland E, Hanahan D (2003) Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. J Clin Investig 111(9):1287\u20131295","journal-title":"J Clin Investig"},{"issue":"1","key":"1709_CR36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0021-9150(99)00295-6","volume":"149","author":"H Uzui","year":"2000","unstructured":"Uzui H, Lee JD, Shimizu H, Tsutani H, Ueda T (2000) The role of protein\u2013tyrosine phosphorylation and gelatinase production in the migration and proliferation of smooth muscle cells. Atherosclerosis 149(1):51\u201359","journal-title":"Atherosclerosis"},{"issue":"4","key":"1709_CR37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0955-2235(89)90014-8","volume":"1","author":"B Westermark","year":"1989","unstructured":"Westermark B, Claesson-Welsh L, Heldin CH (1989) Structural and functional aspects of the receptors for platelet-derived growth factor. Prog Growth Factor Res 1(4):253\u2013266","journal-title":"Prog Growth Factor Res"},{"issue":"7","key":"1709_CR38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3816\/CGC.2007.n.037","volume":"5","author":"DA Bradley","year":"2007","unstructured":"Bradley DA, Dunn R, Nanus D, Stadler W, Dreicer R, Rosenberg J, Smith DC, Hussain M (2007) Randomized, double-blind, placebo-controlled phase II trial of maintenance sunitinib versus placebo after chemotherapy for patients with advanced urothelial carcinoma: scientific rationale and study design. Clin Genitourin Cancer 5(7):460\u2013463","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"1709_CR39","first-page":"597","volume":"5","author":"DW Kim","year":"2004","unstructured":"Kim DW, Lu B, Hallahan DE (2004) Receptor tyrosine kinase inhibitors as anti-angiogenic agents. Curr Opin Investig Drugs 5(6):597\u2013604","journal-title":"Curr Opin Investig Drugs"},{"key":"1709_CR40","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.ajo.2010.04.024","volume":"150","author":"JJ P\u00e9rez-Santonja","year":"2010","unstructured":"P\u00e9rez-Santonja JJ, Campos-Mollo E, Lled\u00f3-Riquelme M, Javaloy J, Ali\u00f3 JL (2010) Inhibition of corneal neovascularization by topical bevacizumab (Anti-VEGF) and sunitinib (anti-VEGF and anti-PDGF) in an animal model. Am J Ophthalmol 150:519\u2013528","journal-title":"Am J Ophthalmol"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1709-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-011-1709-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1709-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T07:55:04Z","timestamp":1637654104000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-011-1709-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,15]]},"references-count":40,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["1709"],"URL":"https:\/\/doi.org\/10.1007\/s00417-011-1709-6","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,15]]}}}